Mangurian, C. V., and L. A. Bero. 2000. Lessons learned from the tobacco industry’s efforts to prevent the passage of a workplace smoking regulation. American Journal of Public Health 90(12):1926–1930.

Markowitz, L. E., E. Dunne, M. Saraiya, H. Lawson, H. Chesson, and E. Unger. 2007. Quadrivalent human papillomavirus vaccine. Morbidity and Mortality Weekly Report 56(RR02):1–24.

Miller, C., M. Wakefield, S. Kriven, and A. Hyland. 2002. Evaluation of smoke-free dining in South Australia: Support and compliance among the community and restauranteurs. Australia and New Zealand Journal of Public Health 26(1):38–44.

Muggli, M. E., R. D. Hurt, and D. D. Blanke. 2003. Science for hire: A tobacco industry strategy to influence public opinion on secondhand smoke. Nicotine and Tobacco Research 5(3):303–314.

Neustadt, R. E., and H. V. Fineberg. 1978. The swine flu affair: Decision-making on a slippery disease. Washington, DC: National Academy Press.

Nissen, S. E., and K. Wolski. 2007. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. New England Journal of Medicine 356(24):2457–2471.

NRC (Nuclear Regulatory Commission). 2012. Risk assessment in regulation. (accessed January 3, 2013).

NTP (National Toxicology Program). 2011. Report on carcinogens, twelfth edition. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. (accessed January 2, 2013).

Ong, E. K., and S. A. Glantz. 2000. Tobacco industry efforts subverting International Agency for Research on Cancer’s second-hand smoke study. Lancet 355(9211):1253–1259.

Oreskes, N., and E. M. Conway. 2010. Merchants of doubt: How a handful of scientists obscured the truth on issues from tobacco smoke to global warming. New York: Bloomberg Press.

Pell, J. P., S. Haw, S. Cobbe, D. E. Newby, A. C. H. Pell, C. Fischbacher, A. McConnachie, S. Pringle, D. Murdoch, and F. Dunn. 2008. Smoke-free legislation and hospitalizations for acute coronary syndrome. New England Journal of Medicine 359(5):482–491.

Petter, A., K. Heim, M. Guger, A. Ciresa–König, N. Christensen, M. Sarcletti, U. Wieland, H. Pfister, R. Zangerle, and R. Höpfl. 2000. Specific serum IGG, IGM and IGA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women. Journal of General Virology 81(3):701–708.

Pursell, L., S. Allwright, D. O’Donovan, G. Paul, A. Kelly, B. J. Mullally, and M. D’Eath. 2007. Before and after study of bar workers’ perceptions of the impact of smoke-free workplace legislation in the republic of Ireland. BMC Public Health 7:131.

Sanders, G. D., and A. V. Taira. 2003. Cost effectiveness of a potential vaccine for human papillomavirus. Emerging Infectious Diseases 9(1):37–48.

Sargent, R. P., R. M. Shepard, and S. A. Glantz. 2004. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: Before and after study. British Medical Journal 328(7446):977–980.

Scallan, E., R. M. Hoekstra, F. J. Angulo, R. V. Tauxe, M. A. Widdowson, S. L. Roy, J. L. Jones, and P. M. Griffin. 2011. Foodborne illness acquired in the United States—Major pathogens. Emerging and Infectious Diseases 17(1):7–15.

Sciacca, J. P., and M. I. Ratliff. 1998. Prohibiting smoking in restaurants: Effects on restaurant sales. American Journal of Health Promotion 12(3):176–184.

Scollo, M., A. Lal, A. Hyland, and S. Glantz. 2003. Review of the quality of studies on the economic effects of smoke-free policies on the hospitality industry. Tobacco Control 12(1):13–20.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement